COVID-19 infection after two doses of SARS-CoV-2 mRNA vaccine in multiple sclerosis, AQP4-antibody NMOSD and MOGAD

BACKGROUND: In pre-vaccinated people with multiple sclerosis (MS), certain disease-modifying therapies (DMTs), particularly the anti-CD20 treatments, appear to be associated with an increased risk of COVID-19 infection and indeed with severe infection. It is still not known if such observations exte...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeo, Tianrong, Quek, Amy May Lin, Yong, Kok Pin, Tye, Janis Siew Noi, Ratnagopal, Pavanni, Soon, Derek Tuck Loong, Tan, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233746/
https://www.ncbi.nlm.nih.gov/pubmed/35803084
http://dx.doi.org/10.1016/j.msard.2022.104003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233746/
https://www.ncbi.nlm.nih.gov/pubmed/35803084
http://dx.doi.org/10.1016/j.msard.2022.104003

Ejemplares similares